Edwards Larry Todd
Insider CIK 1994805 · ARQT See Remarks · ORKA Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2026-08-24 | 2026-08-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award | 2026-08-24 | 2026-08-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2026-08-24 | 2026-08-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award | 2026-08-24 | 2026-08-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-03-02 | 2026-03-03 | 103 | $25.91 | $2.7K | 175,178 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-03-02 | 2026-03-03 | 3,584 | $25.16 | $90.2K | 175,281 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2026-02-27 | 2026-03-03 | 77,000 | — | $0 | 77,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2026-02-27 | 2026-03-03 | 30,000 | — | $0 | 178,865 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-02-02 | 2026-02-04 | 2,052 | $25.50 | $52.3K | 148,865 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-11-06 | 2025-11-10 | 29,131 | $25.16 | $732.9K | 150,193 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-10-02 | 2025-10-06 | 297 | $20.78 | $6.2K | 179,324 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-10-02 | 2025-10-06 | 4,207 | $19.99 | $84.1K | 178,897 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-05-19 | 2025-05-20 | 7,451 | $14.07 | $104.8K | 183,104 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2025-02-28 | 2025-03-04 | 99,000 | — | $0 | 99,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2025-02-28 | 2025-03-04 | 43,000 | — | $0 | 43,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2025-02-28 | 2025-03-04 | 38,000 | — | $0 | 173,555 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2025-02-28 | 2025-03-04 | 17,000 | — | $0 | 190,555 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-02-03 | 2025-02-04 | 2,173 | $12.70 | $27.6K | 135,555 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2024-11-30 | 2024-12-03 | 1,093 | $7.11 | $7.8K | 137,728 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-10-02 | 2024-10-03 | 3,725 | $10.01 | $37.3K | 136,635 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-05-17 | 2024-05-20 | 7,640 | $8.98 | $68.6K | 140,360 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-05-16 | 2024-05-20 | 60,000 | — | $0 | 148,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2024-01-12 | 2024-01-17 | 176,000 | — | $0 | 176,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-01-12 | 2024-01-17 | 28,000 | — | $0 | 88,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2023-09-27 | 2023-10-03 | 240,000 | — | $0 | 240,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2023-09-27 | 2023-10-03 | 60,000 | — | $0 | 60,000 | SEC↗ |